Compare Charles River Laboratories Intl. Inc (CRL) vs iShares MSCI India ETF (INDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs iShares MSCI India ETF — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while iShares MSCI India ETF trades at $46.03 (market cap $5.73B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 2.5× iShares MSCI India ETF's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, iShares MSCI India ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and iShares MSCI India ETF for 58 Days on average.
| CRL | INDA | |
|---|---|---|
Market Cap | $14.23B | $5.73B |
Volume | 1,176,885 | 6,797,522 |
Sector | Health | Broad Market / Factor |
52-Week High | $310.77 | $55.29 |
52-Week Low | $149.93 | $45.42 |
Typical Hold Time | 33 Days | 58 Days |
Enterprise Value | $17.06B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298, down 0.77% on the day, with strong analyst support showing 73% buy ratings and a $305.50 consensus price target. The stock maintains a bullish technical outlook with support at $292 and resistance at $301, while recent earnings have consistently beaten expectations despite negative net income margins. The company's 2026 Investor Day highlighted a strategic vision targeting 5-7% organic growth and $300 million in savings by 2030.
CRL presents a compelling growth story with solid operational cash flow and strategic initiatives, though investors face risks from negative profitability metrics and elevated valuation multiples. The stock's current position near analyst targets suggests limited upside without improved earnings execution, while ongoing margin pressures and debt levels require careful monitoring amid the company's transformation efforts.
INDA trades at $45.56, down 1.21% with bearish technical signals dominating. The ETF faces headwinds from India's economic challenges including coal power shortages, below-average monsoon rains, and IT sector weakness. Technical indicators show oversold conditions with RSI readings below 20, while moving averages signal strong bearish momentum. Recent news highlights energy security concerns and pharmaceutical export challenges affecting the underlying Indian market exposure.
The outlook remains cautious given multiple sector-specific pressures in India. Investment opportunity exists for long-term investors betting on India's growth story at depressed levels, but risks include persistent energy shortages, agricultural output concerns, and global trade tensions that could further pressure the ETF's performance in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About iShares MSCI India ETF
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →
